1-2 of 2
Brian C. Betts
Close
Sort by
Journal Articles

Amphiregulin, ST2, and REG3α biomarker risk algorithms as predictors of nonrelapse mortality in patients with acute GVHD

Aaron Etra, Najla El Jurdi, Nikolaos Katsivelos, Deukwoo Kwon, Stephanie Gergoudis, George Morales, Nikolaos Spyrou, Steven Kowalyk, Paibel Aguayo-Hiraldo, Yu Akahoshi, Francis Ayuk, Janna Baez, Brian C. Betts, Chantiya Chanswangphuwana, Yi-Bin Chen, Hannah Choe, Zachariah DeFilipp, Sigrun Gleich, Elizabeth Hexner, William J. Hogan, Ernst Holler, Carrie L. Kitko, Sabrina Kraus, Monzr Al Malki, Margaret MacMillan, Attaphol Pawarode, Francesco Quagliarella, Muna Qayed, Ran Reshef, Tal Schechter, Ingrid Vasova, Daniel Weisdorf, Matthias Wölfl, Rachel Young, Ryotaro Nakamura, James L. M. Ferrara, John E. Levine, Shernan Holtan
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3284–3292.
https://doi.org/10.1182/bloodadvances.2023011049
Published: 2024
Includes: Supplemental data
Journal Articles

Facilitating resolution of life-threatening acute GVHD with human chorionic gonadotropin and epidermal growth factor

Clinical Trials & Observations
Shernan G. Holtan, Andrea L. Hoeschen, Qing Cao, Mukta Arora, Veronika Bachanova, Claudio G. Brunstein, Jeffrey S. Miller, Armin Rashidi, Arne Slungaard, Celalettin Ustun, Gregory M. Vercellotti, Erica D. Warlick, Brian C. Betts, Najla El Jurdi, Fiona He, Chi Chen, Isha Gandhi, John E. Wagner, Bruce R. Blazar, Pamala Ann Jacobson, Ashraf Shabaneh, Jinhua Wang, Angela Panoskaltsis-Mortari, Margaret L. MacMillan, Daniel J. Weisdorf
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1284–1295.
https://doi.org/10.1182/bloodadvances.2019001259
Published: 2020
Includes: Supplemental data